15.12.2016
- BASF has completed its acquisition of Chemetall from US chemicals and catalyst group Albemarle. The company based at Hamm, Germany, with sales of $845 million in 2015, specializes...
04.07.2016
- The US Food and Drug Administration has approved Gilead Sciences’ combination pill Epclusa, the first to treat all major forms of hepatitis C. This is the latest in a series of...
03.06.2016
- Biogen’s investigational treatment for early Alzheimer’s disease (AD), aducanumab, has been accepted into the European Medicines Agency’s (EMA) PRIority MEdicines (PRIME) program...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
07.10.2015
- With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...
27.07.2015
- The US Food and Drug Administration has designated the Bristol-Mayers Squibb experimental HIV drug BMS-663068 as a breakthrough treatment, which could accelerate its approval. The...
